. Introduction
the anatomical extent and distribution of the vascular obstructions. The ability to augment or accelerate Peripheral vascular disease (PVD) is most commonly neovascularization through the delivery of exogenous caused by arterial obstructions due to advanced atherosgrowth factors has received much attention since this type clerotic lesions and has been reported to affect |12% of of therapy may be a useful adjunct or alternative to the the elderly population [1] . The most common methods of conventional procedures used to treat patients suffering treatment for patients with PVD are surgical revascularizafrom PVD. tion techniques such as bypass procedures, endarterectomy
Early pre-clinical and clinical studies that utilized gene and percutaneous balloon angioplasty. Unfortunately, transfer of angiogenic growth factors, such as vascular many patients are excluded from these procedures due to endothelial growth factor (VEGF), showed promise as an innovative approach to treat patients with critical limb ischemia. However, VEGF gene therapy was also associ-ated with significant adverse effects such as peripheral food and water provided ad libitum. All animal related edema (34% of patients in one study), a condition which is procedures were approved by the Institutional Animal Care also observed in animal models [2, 3] . Other unfavorable and Use Committee at Merck Research Laboratories, West effects associated with VEGF overexpression include Point, PA and conform with the Guide for the Care and formation of fragile ''angioma-like'' capillaries and severe
Use of Laboratory Animals published by the US National neointimal proliferation [4] [5] [6] . Moreover, there have reInstitutes of Health (NIH Publication No. 85-23, revised cently been studies using various animal models of hind-1996) . limb ischemia and different delivery methods that have questioned the functional efficacy of VEGF [3, 4, 7] . These 2 .2. Experimental design studies have demonstrated that although VEGF did stimu-117 late angiogenesis, it did not induce arteriogenesis or
The effect of aFGF-S on collateral-dependent blood improve collateral blood flow. Therefore, due to its uncerflow was assessed in rabbits after unilateral ligation and tain efficacy and mechanism-based adverse effects, the extraction of the femoral artery. We have previously shown clinical utility of VEGF for the treatment of arterial that this method of femoral artery extraction has a transient occlusive disorders has been questioned [8, 9] .
(,5 days) effect on resting blood flow, but a marked and Clearly, it would be favorable to deliver a growth factor prolonged (,40 days) effect on reserve flow [16] . Thus, that could enhance the growth and development of prethese animals serve as a model of intermittent claudication existing vessels (i.e. arteriogenesis), rather than solely and not the more severe critical limb ischemia that is stimulating the sprouting of capillaries (i.e. angiogenesis).
associated with resting pain. Acidic fibroblast growth factor (aFGF or FGF-1) may have For the initial surgery, the rabbits were pre-medicated several therapeutic advantages over VEGF. For example, with xylazine (2.5 mg / kg, i.m.) and anesthetized with unlike VEGF, which is an endothelial cell specific growth ketamine (70 mg / kg, i.m.). Under sterile surgical confactor, aFGF is a powerful mitogen which stimulates ditions, a longitudinal incision was made on the medial migration and proliferation of various cell types, such as thigh of one ''experimental'' hindlimb extending inferiorly smooth muscle cells and fibroblasts which may favor the from the inguinal ligament to a point just proximal to the development of thicker walled vessels. aFGF also stimupatella. Through this incision, the external iliac artery was lates endothelial cell production of matrix metalloproteinisolated, ligated twice and sectioned between the ligatures. ases required for vessel remodeling, and, finally, its high
The distal ligature was used to retract and dissect free the affinity to heparin sulfates on the surface of endothelial entire length of the common femoral artery to the point cells prolongs its half-life and pharmacodynamic action at where it bifurcates into the saphenous and popliteal the FGF-1 receptor. Indeed, aFGF has been shown to be arteries. The ligation of the femoral artery results in active in animal models of dermal wound repair, large retrograde thrombus propagation to the origin of the vessel re-endothelialization and myocardial ischemia [10-external iliac artery. Therefore, blood flow to the hindlimb 13].
after removal of the femoral artery is dependent upon flow The purpose of the present study was to determine if from the internal iliac artery and collateral vessels. All intramuscular administration of the previously described rabbits were closely monitored by veterinary staff and does not diminish the intrinsic mitogenic activity of the the purified recombinant aFGF-S protein at 1 mg / kg protein but substantially increases the half-life of the active (n510), 3 mg/kg (n512), 30 mg/kg (n511), or the mitogen at physiologic temperature and pH both in the vehicle (n512), which contained 0.1 mg / ml human serum absence and presence of heparin [14, 15] . albumin and 12 mg / ml heparin in PBS. Tissue sections (10 mm thickness) were stained for alkaline Twenty days after the initial surgery, resting and reserve phosphatase using the indoxyl-tetrazolium method to dehindlimb blood flow were measured in each rabbit as tect capillary endothelial cells and counterstained with previously described [16] . Briefly, anesthetized rabbits eosin as previously described [16, 18, 19] . The number of were placed in the supine position, intubated and mecapillaries was determined using an image analysis system chanically ventilated with room air. A midline incision was (Phase 3 Imaging) that was programmed to distinguish made in the lower abdomen and the descending aorta was between the dark blue alkaline phosphatase staining of the isolated at the point of bifurcation into the common iliac capillaries and the pink eosin staining of skeletal muscle arteries. The common iliac arteries were then isolated and cells. The system automatically identified and counted the both epigastric arteries were ligated to prevent blood flow number of capillaries in a chosen field (a total of 60 fields to the lateral compartments of the abdomen and pelvic from six different sections were analyzed per muscle). To cavity. Perivascular flow probes (1.5 RB, Transonic Sysensure that capillary density was not overestimated due to tems, Inc.) were placed on the right and left common iliac tissue edema or underestimated due to muscle atrophy, the arteries for continuous and simultaneous measurement of total area of muscle was also determined to produce a blood flow to both limbs. To obtain a functional measure-2 measurement of capillaries / mm of muscle. ment of collateral blood flow, the hyperemic response to a brief arterial occlusion (ao) was measured. An arterial clip was temporarily applied to the common iliac artery and 2 .6. Statistical analysis four separate tests (10, 20, 40 and 60 s in duration) were performed in duplicate with 10 min recovery time allowed
All data are presented as mean6S.E.M. Comparisons between tests. The results are presented as the increase in within the same animal (e.g. experimental vs. contralateral blood volume (ml), which equals the total area under the limb) were performed using a paired Student's t-test. For curve during the first 30 s after release of the arterial clip, intergroup comparisons, a one-way ANOVA followed by minus the baseline blood flow during the time of integraFishers PLSD test for multiple comparisons was used. tion.
Statistical significance was accepted at the P#0.05 level.
.4. Vascular imaging
Following hindlimb blood flow measurements, angiog-3 . Results raphy was performed as previously described by us and 117 others to obtain an anatomical index of the growth and 3 .1. Effect of aFGF-S on resting and reserve development of the larger collateral vessels in the medial hindlimb blood flow portion of the upper hindlimb [16, 17] . For this, a polyethylene catheter was inserted into the common iliac artery When measured 20 days after femoral artery removal, of the experimental limb, with the tip of the catheter there was no significant difference in the resting hindlimb positioned just proximal to the origin of the internal iliac blood flow between the experimental and contralateral artery. The hindlimb was positioned 20 cm below the limbs in any treatment group (Fig. 1 ). This time course of output beam of a fluoroscope (General Electric, Stenosreestablished resting flow is consistent with other reports cop), and the vascular bed was dilated with an intraarterial using similar hindlimb models in rats and rabbits [20, 21] . bolus injection of 300 mg sodium nitroprusside. ImmediIn contrast to the resting flow, reserve blood flow (i.e. ately thereafter, iodinated contrast media (Isovue-370) was collateral-dependent flow) was significantly increased in infused intraarterially at a rate of 60 ml / min. Perfusion of the experimental limbs of rabbits dosed with either 3 or 30 117 the hindlimb was observed on a monitor in real time and mg / kg of aFGF-S (Fig. 2) . There was no difference in an angiographic image was taken exactly 4 s after the start the efficacy observed between the two highest doses of 117 of contrast media infusion. As previously described, a aFGF-S , and the 1 mg / kg dose was not different from circular grid overlay was used by one blinded investigator vehicle-treated rabbits. The reserve blood flow measured in to count the number of vessels that transect a circle to the contralateral limb, which did not undergo surgery or obtain a quantitative measurement of the density of drug treatments, was similar among all groups. It is also collateral vessels in the medial thigh region [16, 17] .
noteworthy that the reserve blood flow capacity measured
.2. Collateral vessel growth and development
Representative angiographic images of the experimental 117 limb from vehicle and aFGF-S treated rabbits are shown in Fig. 3A-D . In response to femoral artery removal, it can be noticed that the internal iliac artery gives rise to supply vessels that transverse the medial thigh region of the limb. Compared to the vehicle treated rabbits, the angiographic images from the rabbits that received 3 and 30 mg/kg of 117 aFGF-S displayed a more dense network of vessels. The increased vascular density was evident by the increased angiographic score in rabbits that were treated with 3 and 117 30 mg / kg of aFGF-S (63.564.7 and 59.766.8, respectively) compared to rabbits that received 1 mg / kg (44.666.2) or the vehicle (40.562.1) (Fig. 4) . top panel) revealed no statistical differences in the capillary density between the experimental and contralateral limb muscles among any treatment group, however, as expected, the capillary density in the white adductor muscle was lower than that of the red gastrocnemius. As can be seen, the capillary density in the gastrocnemius muscles (Fig. 5, bottom panel) of the experimental limb in all groups was higher compared to the non-operated contralateral limb. The elevated capillary density in the gastrocnemius muscle of the experimental limb in the vehicle group is most likely due to the effect of ischemia alone since we observe a similar effect in operated, but untreated rabbits. More importantly, the capillary density in the gastrocnemius muscles obtained from the experimental limbs of the rabbits treated with 3 or 30 mg / kg 117 2 aFGF-S (709669 and 743677 caps / mm , respectively) was significantly increased compared to the corresponding experimental limb of vehicle treated rabbits (539651 2 caps / mm ). 
.4. Effect of aFGF-S on non-ischemic hindlimbs
A separate group of rabbits (n511) was utilized to 117 determine the effects of aFGF-S on the existing hindlimb vasculature in the absence of femoral artery extraction. Normal rabbits underwent a sham operation (i.e. were performed 15 days after the start of dosing. Interestingly, as shown in Table 1, intramuscular administration of   117 aFGF-S into a normal limb had no effect on any of the parameters measured (reserve blood flow, angiographic score or capillary density).
. Discussion
Following arterial occlusion or major stenosis, blood flow through collateral arteries is required to maintain tissue viability. Normally, these collateral vessels are either not present or do not function as major arterial conduits. Enhancing the growth and development of these collateral vessels by the administration of an exogenous growth factor represents an interesting approach for the treatment of arterial occlusive diseases. The primary finding of the present study was that intramuscular administration of a hindlimbs following femoral artery removal, but had no angiogenic or arteriogenic effect in normally perfused limbs.
The results from our study demonstrated that collateraldependent blood flow in the experimental limbs of the 117 rabbits administered 3 and 30 mg / kg of aFGF-S was |70% higher compared to vehicle treated rabbits when measured 20 days after femoral artery removal. The increases in reserve blood flow and angiographic score were similar between the rabbits that received 3 and 30 117 mg / kg, while injections of 1 mg / kg aFGF-S had no effect and were no different from the vehicle group. Thus, 117 maximally effective and no-effect doses of aFGF-S were defined. These results are similar to a previous study by Yang, using a rat model of hindlimb ischemia in which they showed intraarterial administration of bFGF into the iliac artery for 2 weeks at 5 or 50 mg / kg / day was equally effective in stimulating collateral-dependent blood flow, while 0.5 mg / kg / day was less effective [22] . Tabata et al. [23] also showed a similar dose-response profile using plasmid delivery of a secreted form of aFGF in a rabbit model of hindlimb ischemia. In their study, there was no improvement in any of the anatomic or functional parameters with low doses of plasmid (100-300 mg), however a statistically significant increase in these indices was demonstrated at a dose of 500 mg, with no further augmentation at higher doses (700-1000 mg). Furthermore, the There are several reports using various animal models of be observed with alternative dosing protocols and different days of end-point measurement (e.g. 30 or 40 days after effect (i.e. increased capillary sprouting) in a skeletal surgery). However, others have found that bFGF-induced muscle located in the lower hindlimb. This result agrees improvement in hindlimb collateral blood flow in rats was with the work of Ito et al. who, using a similar rabbit independent of the duration of bFGF administration [22] .
model, showed that in the lower limb where the greatest In that report, intraarterial administrations lasting 1, 3, or perfusion deficits occur, endothelial cell proliferation takes 14 days yielded similar increases in calf muscle blood flow place in the absence of smooth muscle cell proliferation, when measured 16 days after femoral artery ligation.
suggesting that angiogenesis predominates over collateral Importantly, in those experiments, the bFGF treatment was remodeling in this region [26] . initiated on the same day as the surgical ligation of the Although the process of arteriogenesis is not completely femoral artery. Those results suggested that the duration of understood, it is not likely related to the metabolic treatment was not as important as the timing of the consequences of ischemia, since the tissue surrounding the treatment as long as it coincided with the onset of collateral conduits has been shown by others to receive ischemia. It has been shown that shortly after the exadequate blood flow [25, 26, 31] . It is more likely that the perimental induction of a vascular occlusion, nearby hemodynamic changes related to increased flow velocity, vessels that likely serve as subsequent collateral conduits wall stress and shear stress, and / or monocyte involvement exhibit proliferative activity and upregulation of certain are important in the remodeling process [29] . Thus, it may growth factor receptors that may be necessary for vascular be that the FGF receptors in the endothelium are upremodeling [26] . Specifically, using a rabbit model similar regulated by these altered flow dynamics leading to an to ours, Deindl and colleagues recently reported increased increased responsiveness to exogenous aFGF. However, it expression of FGF receptor-1 (FGFR-1) during the early is unknown whether the beneficial effects of aFGF are a phase of arteriogenesis [27] . Their elegant immunohistochresult of a primary arteriogenic affect or potentiation of emical studies performed 3 days after femoral artery this activity by facilitating or inducing the activity of other ligation, showed specific localization of FGFR-1 in smooth growth factors. We acknowledge that the beneficial effects 117 muscle cells of the collateral arteries that crossed the of aFGF-S observed in the present study may not be medial thigh region of the limb. Therefore, administration characteristic of a clinical situation, since the method of of an exogenous growth factor, such as aFGF, may only arterial obstruction may have simplified the remodeling need to be present during the ''vascular activation'' or process. Also, prior knowledge of the area of vascular early phase of arteriogenesis which temporally coincides obstruction allowed site-specific delivery of the growth with the development of tissue ischemia or the presence of factor. Nonetheless, it is possible that the advantageous a transcollateral pressure gradient. Thus, the results of our clinical situation may exist where following the identificastudy complement the previous work of others by showing tion of a peripheral vascular obstruction through imaging, 117 117 that responsiveness to aFGF-S was maintained when the site-specific delivery of aFGF-S into the tissue that is initiation of treatment was temporally dissociated from the most likely to respond could minimize side-effects and induction of the vascular obstruction by 5 days.
enhance efficacy. It is well recognized that a flow deficit is a powerful Our results clearly demonstrated that in the absence of 117 stimulus for vascular remodeling, even without the interfemoral artery extraction, aFGF-S had no effect on any vention of an exogenous growth factor(s) [16, 26] . The of the parameters of angiogenesis, arteriogenesis and remodeling of existing vessels to form functional arterial hindlimb blood flow. When a previously determined effec-117 conduits has been termed ''arteriogenesis'', and is clearly tive dose of aFGF-S was administered to normal rabbit distinct from de novo formation of new capillaries by the limbs with an intact femoral artery, we found no changes process of angiogenesis. In response to a vascular stenosis in limb blood flow (resting or reserve), angiographic score or occlusion, it is arteriogenesis which is believed to be the or capillary density. These results suggest that adequately more important and compensatory form of vascular growth perfused skeletal muscle is unresponsive to exogenous required to maintain tissue perfusion [7, 16, 28] . Although aFGF and, to our knowledge, this is the first evidence arteriogenesis was observed via angiography in all animals showing that existing vessels that ultimately serve as in the present study, in contrast to the modestly defined collateral conduits are unresponsive to aFGF, unless a 117 arterial tree seen in the vehicle group, the aFGF-S vascular obstruction exists in the region. This finding treated animals exhibited an expanded vascular tree that supports the idea that creation or formation of a vascular was more dense and extended further distally. These obstruction produces site-specific alterations in nearby results are consistent with previous studies using rat and vessels which allow them to become responsive to exogenrabbit models of hindlimb ischemia that showed intraarterious aFGF. al administration of bFGF into the hindlimb led to inAlthough the increased reserve blood flow measured in 117 creased proliferation of endothelial and smooth muscle response to aFGF-S treatment appeared to be physiologcells [29] , enlargement of existing conduit vessels and ically relevant, we did not evaluate its impact on exercise increased collateral-dependent blood flow [25, 29, 30] . It is tolerance or muscle function. However, using a rat model 117 also interesting to note that aFGF-S had an angiogenic of hindlimb ischemia, it has been shown that improve- aFGF-S would translate into improved efficacy in vivo 
